Evidence map›Paper›PMID 31891134›Full record

ArticleEClinicalMedicine2019

Levels of clinical condom failure for anal sex: A randomized cross-over trial.

Aaron J Siegler, Elizabeth M Rosenthal, Patrick S Sullivan, C Christina Mehta, Reneé H Moore, Lauren Ahlschlager, Colleen F Kelley, Eli S Rosenberg, Michael P Cecil

Registry-linked trialAbstract read
In one paragraph

Article in EClinicalMedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02753842 (A Double-Blind, Single Center, Randomized 3-way Crossover Trial to Determine Pleasure for Fitted, Thin and Standard Condoms, and to Assess Clinical Failure for Vaginal and Anal Sex), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02753842 nacompletednot on this map

A Double-Blind, Single Center, Randomized 3-way Crossover Trial to Determine Pleasure for Fitted, Thin and Standard Condoms, and to Assess Clinical Failure for Vaginal and Anal Sex

TypeinterventionalSponsorGlobal Protection Corp.Ran2016 to 2017Enrolled504ConditionsHIVArms5 Fitted Condoms, 5 Thin Condoms, 5 Standard Condoms
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aaron J SieglerDepartment of Behavioral Sciences and Health Education Rollins School of Public Health at Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, United States of America.
Elizabeth M RosenthalDepartment of Epidemiology Rollins School of Public Health at Emory University, United States of America.
Patrick S SullivanDepartment of Epidemiology Rollins School of Public Health at Emory University, United States of America.
C Christina MehtaDepartment of Biostatistics and Bioinformatics Rollins School of Public Health at Emory University, United States of America.
Reneé H MooreDepartment of Biostatistics and Bioinformatics Rollins School of Public Health at Emory University, United States of America.
Lauren AhlschlagerDepartment of Epidemiology Rollins School of Public Health at Emory University, United States of America.
Colleen F KelleyEmory University School of Medicine, United States of America.
Eli S RosenbergDepartment of Epidemiology Rollins School of Public Health at Emory University, United States of America.
Michael P CecilTheyFit, LLC, United States of America.

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
A study to improve the fit of HIV prevention methodsR44HD078154 · NICHD · THEYFIT, LLC · PI BOOS, ELIZABETH MARIE, CECIL, MICHAEL P · 2014 to 2015
$1.5M
NIAID NIH HHS P30 AI050409NICHD NIH HHS R44 HD078154
6 · The paper itself

Abstract

backgroundMen who have sex with men (MSM) face a 28-fold higher risk of HIV acquisition than men who have sex with women (MSW). Condoms are the most accessible prevention method, with billions produced annually. Due to potentially high clinical failure, international regulatory agencies do not approve condoms for anal sex. This trial sought to provide data regarding approval of condoms for anal sex.

methodsWe conducted a blinded, crossover randomized trial among MSM and MSW in Atlanta, Georgia, USA. Crossover conditions were standard condoms, thin condoms, and condoms fitted to each user's penile dimensions. The primary outcome was total clinical failure (slippage and/or breakage), assessed using an intention-to-treat analysis. A mixed methods model assessed differences in odds of failure. The study is registered with ClinicalTrials.gov, NCT02753842, and is completed.

findingsWe enrolled 252 MSM and 252 MSW between May 19, 2016 and May 2, 2017. Participants reported a total of 4884 anal or vaginal sex acts using study-provided condoms. For all crossover conditions, clinical failure was lower for anal sex (0•7%, 16/2351) than for vaginal sex (1•9%, 48/2533), (odds ratio 0•40, 95% confidence interval 0•21, 0•75,

interpretationIn the largest trial of effectiveness of condoms for anal sex to date, we found remarkably low levels of failure. Condoms should be approved by regulatory agencies for anal sex. Clinicians may recommend condoms as a highly efficacious HIV and STD prevention tool for anal sex. Differences between failure for anal and vaginal sex were likely due to differential use of lubricant. Condom promotion programs should consider providing additional lubricant for all condoms distributed.

Identifiers

PMID31891134
PMCPMC6933145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.